ID: 2849 | Pages: 130 | August 2017 | Region: Asia Pacific
The Asia Pacific High Resolution Melting Analysis Market was worth $51.78 million in 2016 and is projected to be growing at a CAGR of 5.2%, to touch $66.72 million by 2021. During the process of High Resolution Melting Analysis, double stranded DNA is split between temperature ranging from 50 to 90 degree Celsius, the process of splitting is studied and compared with the splitting of a normal person’s DNA, and the differences are noted which give insights about the presence of mutations and other abnormalities.
High Resolution Melting Analysis or HRM Analysis is used for the identification of polymorphisms, mutations and epigenetic differences.
Driving factors of the Asia-Pacific High Resolution Melting Analysis Market include the vast regional population base which results in increasing frequency of infectious diseases and genetic ailments, improving healthcare infrastructure, rising public-private investments in the genomics sector and the upsurge in the count of elderly populace. The market is also driven by the benefits that HRM offers over its counterparts like genotyping, which are its higher efficiency, high accuracy and smaller cycle times.
The Asia-Pacific High Resolution Melting Analysis Market is segmented on the basis of Product and Service, Application, End User and geography. Based on Product and Service, the market is divided into Instruments, Reagents and Consumables, Software and Services. Based on Application, the High Resolution Melting Analysis Market is segmented into Mutation Discovery, SNP Genotyping, Species Identification, Pathogen Identification, Epigenetics, and Other Applications. Based on the End User, the market is categorized into Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Hospitals and Diagnostic Centers and others.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as growing demographics with rising awareness and growing disposable incomes, due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. In fact, Asia-Pacific is the fastest developing HRM market. Availability of humongous untapped markets and huge population base are driving the upsurge in growth.
The significant players in the Asia-Pacific High Resolution Melting Analysis Market include Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). Other players in the market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product and Service
5.1.1 Introduction
5.1.2 Reagents and Consumables
5.1.2.1 Specialized Pcr Reagents
5.1.2.2 Intercalating Dyes
5.1.3 Instruments
5.1.4 Software and Services
5.1.5 Y-o-Y Growth Analysis, By Product and Service
5.1.6 Market Attractiveness Analysis, By Product and Service
5.1.7 Market Share Analysis, By Product and Service
5.2 Application
5.2.1 Introduction
5.2.2 SNP Genotyping
5.2.3 Mutation Discovery
5.2.4 Species Identification
5.2.5 Pathogen Identification
5.2.6 Epigenetics
5.2.7 Other Applications
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Research Laboratories and Academic Institutes
5.3.3 Pharmaceutical and Biotechnology Companies
5.3.4 Hospitals and Diagnostic Centres
5.3.5 Other End Users
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product and Service
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product and Service
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product and Service
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F. Hofmann-La Roche Ltd.
8.3 Bio-Rad Laboratories
8.4 QIAGEN N.V.
8.5 Agilent Technologies Inc.
8.6 BioMérieux S.A.
8.7 Illumina, Inc.
8.8 Meridian Bioscience, Inc.
8.9 Azura Genomics
8.10 Canon Biomedical
8.11 PREMIER Biosoft
8.12 Novacyt
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Title | Price | Add To Cart |
© 2018 Market Data Forecast
All Rights Reserved.